Related Experiment Video
Updated: Jul 14, 2026

Inducing Apical Periodontitis in Mice
Published on: August 6, 2019
Vasoactive intestinal peptide receptor expression in chronic periapical lesions
J Caviedes-Bucheli1, M M Azuero-Holguín, G C Moreno
1Department of Graduate Studies, School of Dentistry, Pontificia Universidad Javeriana, Bogota, Colombia. javiercaviedes@cable.net.co
Aim:
To use radioreceptor analysis for evaluating whether vasoactive intestinal peptide (VIP) receptors are present in chronic periapical lesions and to determine whether differences in its expression are found according to the size of the lesions.
Methodology:
Twelve periapical lesions were obtained from teeth diagnosed with chronic apical periodontitis and indicated for endodontic surgery; they were classified according to the size of the lesion in two groups of six samples (lesion size greater or smaller than 5 mm), and then processed and labelled with (125)I-VIP. Binding sites were identified by (125)I-VIP and standard VIP competition assays. Mann-Whitney's test was used to establish statistically significant differences in the VIP receptor expression between groups.
Results:
Vasoactive intestinal peptide receptor expression was found in all periapical lesion samples. There was a statistically significantly higher expression in periapical lesions <5 mm (P < 0.001).
Conclusion:
Vasoactive intestinal peptide receptors were expressed in chronic periapical lesions with levels inversely proportional to lesion size.
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Inflammatory Bowel Disease II: Ulcerative Colitis
